Asset Management One Co., Ltd. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Asset Management One Co., Ltd. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$597,000
+2.8%
17,059
+57.0%
0.00%0.0%
Q2 2020$581,000
+50.9%
10,8630.0%0.00%
+50.0%
Q1 2020$385,000
-25.8%
10,8630.0%0.00%0.0%
Q4 2019$519,000
+47.4%
10,8630.0%0.00%0.0%
Q3 2019$352,000
-35.1%
10,8630.0%0.00%
-33.3%
Q2 2019$542,000
-26.1%
10,8630.0%0.00%
-25.0%
Q1 2019$733,000
+50.5%
10,8630.0%0.00%
+300.0%
Q4 2018$487,000
-41.1%
10,8630.0%0.00%
-50.0%
Q3 2018$827,000
-8.1%
10,8630.0%0.00%0.0%
Q2 2018$900,000
+1.4%
10,8630.0%0.00%0.0%
Q1 2018$888,000
+34.7%
10,8630.0%0.00%
+100.0%
Q4 2017$659,000
-78.9%
10,863
-77.4%
0.00%
-85.7%
Q3 2017$3,126,000
+23.9%
48,1110.0%0.01%
+16.7%
Q2 2017$2,523,000
+2.8%
48,111
+12.4%
0.01%0.0%
Q1 2017$2,454,000
+57.2%
42,803
+17.1%
0.01%
+50.0%
Q4 2016$1,561,000
-57.6%
36,557
-48.5%
0.00%
-92.7%
Q3 2016$3,680,000
+145.0%
71,030
+110.8%
0.06%
+139.1%
Q2 2016$1,502,000
-27.7%
33,694
-38.6%
0.02%
-23.3%
Q1 2016$2,077,000
-35.4%
54,838
+15.2%
0.03%
-37.5%
Q4 2015$3,215,000
+0.3%
47,623
+1.4%
0.05%
-2.0%
Q3 2015$3,206,000
-40.0%
46,966
-8.2%
0.05%
-33.8%
Q2 2015$5,340,000
-8.1%
51,163
-13.0%
0.07%
+2.8%
Q1 2015$5,809,000
+58.8%
58,800
+85.8%
0.07%
+53.2%
Q4 2014$3,658,00031,6500.05%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders